Application 203791
- Type
- NDA
- Sponsor
- EPI HLTH
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SITAVIG | ACYCLOVIR | TABLET;BUCCAL | 50MG | Yes | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 68712-049 | Sitavig | Acyclovir | Cipher Pharmaceuticals US LLC | NDA | Current |
| 71403-049 | Sitavig | Acyclovir | EPI Health, Inc | NDA | Current |
| 71403-049 | Sitavig | Acyclovir | EPI Health, Inc | NDA | Current |
| 71403-049 | Sitavig | Acyclovir | EPI Health, Inc | NDA | Current |